| 200961-1G |
|
4984-22-9 |
(2R)-1-Methoxy-2-propanol
≥98%,99%e.e.
|
1G |
C4H10O2 |
|
|
|
| 200955-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C32H21Br3N3O·BF4 |
|
|
|
| 200954-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C32H21Br3N3O·BF4 |
|
|
|
| 200953-100MG |
|
NA |
(5aS?,?10bR)?-?5a,?10b-?Dihydro-5-?(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C33H21F3Br2N3O·BF4 |
|
|
|
| 200952-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C33H21F3Br2N3O·BF4 |
|
|
|
| 200937-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(1-naphthalene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C28H19Br3N3O·BF4 |
|
|
|
| 200951-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(1-naphthalenyl)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C28H19Br3N3O·BF4 |
|
|
|
| 200936-100MG |
|
NA |
(5aS,?10bR)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C24H17Br3N3O·BF4 |
|
|
|
| 200950-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C24H17Br3N3O·BF4 |
|
|
|
| 200935-100MG |
|
NA |
(5aS?,?10bR)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C19H13F3Br2N3O·BF4 |
|
|
|
| 200949-100MG |
|
NA |
(5aR,?10bS)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate
≥98%,99%e.e.
|
100MG |
C19H13F3Br2N3O·BF4 |
|
|
|
| 200929-25G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
25G |
C5H12N2O?HCl |
|
|
|
| 200929-5G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
5G |
C5H12N2O?HCl |
|
|
|
| 200929-1G |
|
133170-58-8 |
D-Valinamide Hydrochloride
≥98%,99%e.e.
|
1G |
C5H12N2O?HCl |
|
|
|
| 200927-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
1G |
C45H55O4P |
|
|
|
| 200927-100MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
100MG |
C45H55O4P |
|
|
|
| 200927-25MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C45H55O4P |
|
|
|
| 200926-1G |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
1G |
C45H55O4P |
|
|
|
| 200926-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥95%,99%e.e.
|
100MG |
C45H55O4P |
|
|
|
| 200926-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C45H55O4P |
|
|
|
